First of all don’t confuse earnings and revenue. BOT may bring in 100mil plus revenue, but only make 30 mil earnings (small earnings for initial 100mil).
if BOT went from $0 revenue to $100 mil revenue in 12-18 months the market would get very excited and put a high revenue multiple on the company between 10-20 perhaps.
Price to Earnings is dictated by how fast the earnings/or potential earnings are growing. If BOT goes from generating no earnings to $30 mil in 12-18 months the market will give it a high P/E if it expects a blockbuster drug and the earnings to grow exponentially for a couple of years. Maybe 30-50 P/E.
this is how I understand it, only way to be more accurate is to do reverse cash flow analysis.
Ann: Investor Webinar Presentation, page-16
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |